JG
NKGNW

Jefferies Group’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Jefferies Group’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.85K Hold
35,000
– – ﹤0.01% 1576
2022
Q2 		$9.1K Hold
35,000
– – ﹤0.01% 1472
2022
Q1 		$21.2K Hold
35,000
– – ﹤0.01% 1447
2021
Q4 		$40.3K Hold
35,000
– – ﹤0.01% 1527
2021
Q3 		$40.6K Buy
+35,000
New +$43.7K ﹤0.01% 1614

Other funds holding NKGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Jefferies Group's NKGNW Position: Q3 2022 in Review

Jefferies Group held its NKGen Biotech, Inc. Warrants (NKGNW) position steady in Q3 2022 at 35,000 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Jefferies Group first reported a position in NKGNW in Q3 2021 and has held it in 5 quarters since. The position peaked at $40.6K in Q3 2021. 32 funds tracked by Wall St. Rank hold NKGNW as of Q3 2022.

  • Jefferies Group held 35,000 shares of NKGen Biotech, Inc. Warrants worth $3.85K as of Q3 2022.
  • Jefferies Group left its NKGen Biotech, Inc. Warrants share count unchanged in Q3 2022.
  • NKGen Biotech, Inc. Warrants made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1576 holding.
  • Jefferies Group first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and has held it in 5 quarters since.
  • Jefferies Group's NKGen Biotech, Inc. Warrants position peaked at $40.6K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.